Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Exonuclease-mediated degradation of nascent RNA silences genes linked to severe malaria

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Repositioning of the global epicentre of non-optimal cholesterol

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Patterns of somatic structural variation in human cancer genomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Qingfeng Zhang
  • T Nicolai Siegel
  • Rafael M Martins
  • Xue Fei Wang
  • Jun Cao
  • Qi Gao
  • Xiu Cheng
  • Lubin Jiang
  • Chung-Chau Hon
  • Christine Scheidig-Benatar
  • Hiroshi Sakamoto
  • Louise Turner
  • Anja T R Jensen
  • Aurelie Claes
  • Julien Guizetti
  • Nicholas A Malmquist
  • Artur Scherf
View graph of relations

Antigenic variation of the Plasmodium falciparum multicopy var gene family enables parasite evasion of immune destruction by host antibodies. Expression of a particular var subgroup, termed upsA, is linked to the obstruction of blood vessels in the brain and to the pathogenesis of human cerebral malaria. The mechanism determining upsA activation remains unknown. Here we show that an entirely new type of gene silencing mechanism involving an exonuclease-mediated degradation of nascent RNA controls the silencing of genes linked to severe malaria. We identify a novel chromatin-associated exoribonuclease, termed PfRNase II, that controls the silencing of upsA var genes by marking their transcription start site and intron-promoter regions leading to short-lived cryptic RNA. Parasites carrying a deficient PfRNase II gene produce full-length upsA var transcripts and intron-derived antisense long non-coding RNA. The presence of stable upsA var transcripts overcomes monoallelic expression, resulting in the simultaneous expression of both upsA and upsC type PfEMP1 proteins on the surface of individual infected red blood cells. In addition, we observe an inverse relationship between transcript levels of PfRNase II and upsA-type var genes in parasites from severe malaria patients, implying a crucial role of PfRNase II in severe malaria. Our results uncover a previously unknown type of post-transcriptional gene silencing mechanism in malaria parasites with repercussions for other organisms. Additionally, the identification of RNase II as a parasite protein controlling the expression of virulence genes involved in pathogenesis in patients with severe malaria may provide new strategies for reducing malaria mortality.

Original languageEnglish
Issue number7518
Pages (from-to)431-5
Number of pages5
Publication statusPublished - 18 Sep 2014

    Research areas

  • Alleles, Antigenic Variation, Chromatin, Down-Regulation, Erythrocytes, Exoribonucleases, Gene Silencing, Genes, Protozoan, Humans, Introns, Malaria, Cerebral, Malaria, Falciparum, Plasmodium falciparum, Promoter Regions, Genetic, Protozoan Proteins, RNA, Messenger, RNA, Protozoan, RNA, Untranslated, Transcription Initiation Site, Virulence, Virulence Factors

ID: 44940338